NCT07048886View on ClinicalTrials.gov

Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 15, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Primary Open Angle Glaucoma
Interventions
DRUG

Rocklatan (netarsudil 0.02% and latanoprost 0.005%)

Additional intraocular eye pressure lowering post-Hydrus

DRUG

Systane

Placebo Comparator (artificial tears)

Trial Locations (1)

89145

Center for Sight, Las Vegas

All Listed Sponsors
lead

Center for Sight Las Vegas

OTHER